Research focus

Cancer Trials New Zealand (CTNZ) was established in 2003 as a national clinical trial coordination centre to foster and conduct research that improves outcomes and reduces inequity for people with cancer in Aotearoa New Zealand. CTNZ partners with researchers and Cancer Centres throughout New Zealand to develop clinical questions into externally funded clinical research studies and provides the expertise necessary to conduct these to best international practice standards.

Key Contacts

Professor Michael Findlay (CTNZ Director)

Dr Sarah Benge (CTNZ Research Operations Manager)

NETwork! is a national alliance between clinicians and scientists to manage and study neuroendocrine cancers (NETs). NETs are uncommon and very diverse, making them difficult to diagnose and treat. NETwork! combines clinical practice and scientific expertise to improve outcomes for NET patients.

Key Contacts

Dr Ben Lawrence (Head of Oncology and Medical Oncologist)
 

An easily accessed, comprehensive registry that includes all tumour types and measures of local clinical outcomes is not currently available to oncologists.

This group is a clinical-academic collaboration aiming to synthesise data generated in the clinical setting from multiple sources including MDM records, electronic prescribing software and hospital clinical records.
Establishing a high quality, prospective clinical database of treatments and outcomes for patients in the Auckland region with cancer will:

• Improve clinical care through nimble quality assurance, highlighting inequities and timely feedback to clinicians.
• Facilitate research and well-governed collaboration to answer questions that can improve outcomes for cancer patients.
• Be a foundation of measuring improvement as an integrated academic cancer service evolves in the Auckland region.
• Align with and supplement national data collection and improvements underway with Te Aho o Te Kahu.